SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-18-008844
Filing Date
2018-02-16
Accepted
2018-02-16 17:07:32
Documents
1
Period of Report
2018-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 3/A doc1.html 3/A  
1 FORM 3/A doc1.xml 3/A 5729
  Complete submission text file 0001140361-18-008844.txt   7477
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Reporting) CIK: 0001404574 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-36020 | Film No.: 18622078